LC-MS/MS Thiol Quantification for Oxidative Stress Biomarkers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current assays for determining thiol and disulfide-containing molecules in samples, such as plasma, are not sensitive or high-throughput enough to effectively assess oxidative stress or respond to antioxidant treatments, leading to unreliable biomarker evaluation for various disease states.

Innovation Solution

An ultra-performance LC-MS/MS method with Multiple Reaction Monitoring (MRM) is employed, where samples are treated with a reagent to prevent free thiol oxidation, isotopically labeled analogues are added, and methanol is used for extraction, allowing for the determination of reduced and oxidized forms of thiol and disulfide-containing molecules like GSH, cysteine, and protein-bound species.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If enzymatic recycling methods are used for GSH/GSSG assay, then the assay can be performed with commercially available kits, but the quantification variation is high due to artificial oxidation susceptibility

Engineering Contradiction:
Improveavailability of commercial kitsVSAvoidquantification variation
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent replaces enzymatic recycling methods with direct LC-MS/MS detection. Instead of using enzymatic reactions that are prone to artificial oxidation, the method directly measures GSH and GSSG levels through mass spectrometry, eliminating the enzymatic step that causes quantification variation while maintaining commercial kit availability through standardized protocols

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces stable isotopically labeled internal standards (GSH-d4, GSSG-d4) as intermediaries to correct for variability. These labeled standards are added to samples before processing and serve as reference points during LC-MS/MS detection, allowing normalization of quantification data and reduction of variation caused by artificial oxidation during assay performance

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If GSH/GSSG ratio is used as biomarker, then oxidative stress can be assessed in whole blood and red blood cells, but the sensitivity is insufficient for plasma samples due to lower extracellular concentration

Engineering Contradiction:
Improveapplicability to different sample typesVSAvoiddetection sensitivity
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent changes the detection parameter from enzymatic activity measurement to direct mass spectrometry detection. LC-MS/MS provides significantly higher sensitivity and detection limits compared to enzymatic methods, enabling reliable measurement of low-concentration GSH/GSSG in plasma while maintaining the ability to assess oxidative stress across multiple sample types including whole blood, red blood cells, and plasma

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses stable isotopically labeled analogs (GSH-d4, GSSG-d4, Cys-d3, Cystine-d6) as internal standards that are added to all samples. These labeled copies of the target molecules serve as reference points for quantification, allowing accurate measurement of endogenous GSH and GSSG levels even at low concentrations in plasma samples

Inventive Principle:
Principle #26Copying

3Loss of information

If protein bound Cysteine is used as oxidative stress indicator, then additional biomarker information can be obtained, but no sensitive and high throughput assay is available

Engineering Contradiction:
Improvebiomarker information completenessVSAvoidassay throughput
Core Design Contradiction:
Loss of informationVSProductivity

Solution Approach 1:

The patent creates a universal LC-MS/MS assay that can simultaneously measure multiple biomarkers including free GSH, GSSG, cysteine, cystine, N-acetyl-cysteine, and their disulfide forms, as well as protein-bound forms. This single multi-functional method replaces the need for separate assays for each biomarker, providing comprehensive oxidative stress information while achieving high throughput through efficient sample preparation and analysis

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent merges the measurement of multiple thiol-containing biomarkers into a single integrated LC-MS/MS assay. By combining detection of free thiols, disulfides, N-acetyl derivatives, and protein-bound forms in one analytical run, the method achieves high throughput while capturing complete biomarker information, eliminating the need for multiple separate testing procedures

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a reliable and sensitive means to quantify thiol and disulfide levels, effectively indicating oxidative stress and enabling the evaluation of disease status and response to antioxidant treatments, with results showing significant increases in oxidized forms in patients with conditions like sickle cell disease and acute respiratory distress syndrome.

Implementation Method 1

treating a sample with a reagent to prevent free thiol oxidation

Methodology Applied
Scientific EffectThiol blocking: Chemical Bonding

Implementation Method 2

adding methanol to extract the molecules

Methodology Applied
Scientific EffectLiquid-liquid extraction: Liquid-Liquid Extraction

Implementation Method 3

liquid chromatography-tandem mass spectrometry (LC-MS/MS) with Multiple Reaction Monitoring (MRM)

Methodology Applied
Scientific EffectElectrospray ionization: Ionisation

Implementation Method 4

liquid chromatography-tandem mass spectrometry (LC-MS/MS)

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 5

subjecting the sample to liquid chromatography-tandem mass spectrometry (LC-MS/MS) with Multiple Reaction Monitoring (MRM) to determine the levels

Methodology Applied
Scientific EffectMass spectrometry detection: Ionisation

Data Source

PatentUS10705093B2Determination of small-molecule thiols and disulfides: protein bound cys and total cysteine as biomarkers of oxidative stress
Publication Date: 2020.07.07 BLOODWORKS
  • US10705093B2 patent drawing
  • US10705093B2 patent drawing
  • US10705093B2 patent drawing

AI summary

Compositions and methods for determining the level of thiol and disulfide containing molecules in a sample are provided. The compositions and methods can be used to determine the level of oxidative stress in a subject with or without antioxidant treatment. Also provided are biomarkers of oxidative stress.